Oaklins’ team in Los Angeles has advised the shareholders of Ambry Genetics Corporation, a clinical diagnostics testing services provider, on the sale of the company to Konica Minolta, Inc.
This powerful combination will bring the most comprehensive genetic diagnostic solutions to Japan, Europe and globally.
Read more about the transaction, market trends, deal drivers and M&A valuation aspects.
© 2019 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.